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The vascular effects of histamine are clearly
apparent in urticaria where the released histamine
is responsible for some of the exudatory and
vasodilatatory reactions (1—4).
Adam, Hunter and Kinnear (5) demonstrated
that there may be an increase of urinary free
histamine during urticaria and recently Brogren,
DunOr, Hamrin, Pernow, Theander and Walden-
strom (6) made similar observations on great
histamine excretion in urticaria pigmentosa, in
which condition large amounts of histamine are
present in mast cell infiltrations.
Only a small part of injected histamine is
excreted in urine (7, 8, 9) and histamine disap-
pears very rapidly from the blood (7, 8). These
facts may be explained by a rapid catabolism of
histamine.
Best and McHenry (10) were the first who
called attention to enzymes which could catab-
olize histamine. They proposed the name hista-
minase for the histamine-inactivating enzyme,
but Zeller (11) found that the enzyme could oxi-
dize several diamines and therefore suggested
that it should be called diamine oxidase.
It has recently become possible to study the
catabolism of histamine in man more extensively.
Schayer and Cooper (12) injected histamine
labelled with C'4 in the imidazole-ring, and
studied the urinary excretion of histamine and
histamine metabolites. They found that methyla-
tion of histamine to 1-methyl-4-beta-aminoethyl
imidazole followed by oxidation of the formed
methylhistamine was the main metabolic path-
way, but oxidation of histamine to imidazole
acetic acid was also of importance. Only a few
per cent of the injected histamine was excreted
in unchanged form. Nilsson, Lindell, Schayer and
Westling (13) studied histamine metabolism in
pregnancy, and Lindell, Nilsson and Rorsman,
in cold urticaria (14). They found essentially the
same excretion of metabolites as did Schayer and
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Cooper (12) in normals. Methylation of histamine
through histamine methyl-transferase (15) is thus
an important catabolic pathway of histamine in
man.
It is known that the metabolite of histamine,
1-methyl-4-beta-aminoethyl imidazole, has less
biologic effect than histamine (16). Lee and Jones
(17) studied the effects of derivatives of histamine
and assayed the spasmogenic effect on the iso-
lated guinea-pig ileum and the depression of blood
pressure in the anesthetized cat. They concluded
that the minimal requirement for histamine
activity was the following chemical configuration:
—CCH,CH2NH, or —CCH2CH2NH,
N N/
Lee and Jones found that the activity of
methyl-histamine on guinea-pig ileum was 0.6
per cent of that of histamine, and that the effect
of methyl-histamine on cat blood pressure was 0.2
per cent of that of histamine. Westling (18)
studied the bronchoconstrictory action of methyl-
histamine and histamine in the guinea-pig and
found that the methylated derivative was about
200 times less active than histamine.
No data on the effects of methyl-histamine in
man are available. As this substance is an im-
portant product of histamine catabolism we
have considered it of importance to study to
what extent methylation of histamine means
inactivation of the amine. The exudatory and
vasodilatatory effects of methyl-histamine and
histamine in the skin have therefore been studied
in ten human subjects.
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MATERIAL AND METHODS
Ten healthy individuals, nine males and one
female, 19 to 28 years old, were used for the study.
All had normal exudatory response to intracu-
taneously injected histamine (19).
Using 1 ml syringes and needles of 0.40—0.50 mm
external diameter, 0.1 ml was injected intracu-
taneously in vertical rows on the back, about 10
cm from the vertebral column.
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For the purpose of studying the exudatory
effects of histamine and methyl-histamine, 0.1
ml/kg body-weight of 4 per cent sodium fluorescein
in distilled water was injected intravenously im-
mediately after the intradutaneous injections.
Within 3 minutes the tests were read under Wood's
light produced by one lamp with a maximum at
3650 A. Tests with definite yellow-green fluores-
cence on the whole surface of the wheal produced
by the injection were considered positive. Tests
with saline and those considered negative pro-
duced no fluorescence or only a slight one limited
to the site of the injection trauma.
The flare responses were observed in day light
between 5 and 10 minutes after the intracutaneous
injections. A definite flare surrounding the raised
bleb was considered positive.
After 48 hours the injection sites were examined
for delayed inflammatory reactions.
The dilutions were calculated as weight per voi-
ume. Twofold serial dilutions from 1:1000 to
1:64,000 of methyl-histamine * prepared according
to the method of Rotschild and Schayer (20) were
injected. Histamine was injected in the following
dilutions: 1:10,000, 1:100,000, and twofold serial
dilutions from 1:1,000,000 to 1:64,000,000. All di-
lutions were prepared with 0.85 per cent saline.
0.85 per cent saline was used for control injections.
RESULTS
The exudatory effect of methyl-histamine and
histamine can be seen in table 1. One subject
reacted with exudation to a dilution of 1:8,000
of methyl-histamine, two subjects to a dilution
of 1:4,000, and six subjects to a dilution of
1:2,000. One subject reacted only to 1:1,000.
With histamine, one subject reacted to
1:16,000,000, two subjects to 1:8,000,000, four
subjects to 1:4,000,000 and three subjects to
1:2,000,000. None of the subj ects demonstrated
any exudation to the control injections with
saline.
The vasodilatatory effect is illustrated in table
2. Methyl-histamine produced vasodilatation in
a dilution of 1:32,000 in one subject, in 1:16,000
in one subject, in 1:4,000 in one subject. in
1:2,000 in three subjects, and in 1:1,000 in two
subjects. In two subjects, not even 1:1,000
produced any noticeable vasodilatation.
Histamine produced a "flare" in 1:16,000,000
in three subjects, in 1:2,000,000 in one subject,
in 1:1,000,000 in four subjects, and all reacted
* We thank Miss Karen Nilsson, Department of
Physiology, University of Lund, Sweden, for the
supply of this substance.
TABLE 1
The lowest concentrations of methyl-histamine and
histamine inducing exudation (g/ml)
Methyl-histamine Histamine Ratio
1 1:2,000 1:2,000,000 1000
2 1:2,000 1:4,000,000 2000
3 1:4,000 1:4,000,000 1000
4 1:2,000 1:2,000,000 1000
5 1:2,000 1:8,000,000 4000
6 1:8,000 1:16,000,000 2000
7 1:2,000 1:8,000,000 4000
8 1:1,000 1:4,000,000 4000
9 1:2,000 1:4,000,000 2000
10 1:4,000 1:2,000,000 500
TABLE 2
The lowest concentrations of methyl-histamine and
histamine inducing vasodilatation (g/ml)
I1re Histamine Ratio
1 1:100,000 >100
2 1:1,000 1:1,000,000 1000
3 1:2,000 1:2,000,000 1000
4 1:4,000 1:16,000,000 4000
5 1:16,000 1:16,000,000 1000
6 1:32,000 1:16,000,000 500
7 1:1,000 1:1,000,000 1000
8 1:2,000 1:1,000,000 500
9 1:2,000 1:1,000,000 500
10 1:100,000 >100
with vasodilatation to the dilution of 1:100,000.
One of the subjects with vasodilatatory reaction
to a dilution of 1:16,000,000 of histamine, and
to 1:32,000 of methyl-histamine, demonstrated
a slight vasodilatation to saline as well.
Histamine is thus more than a thousand times
more efficient in inducing exudation than its
catabolic derivative, methyl-histamine, and is
about one thousand times more active as a
vasodilatator than methyl-histamine.
No delayed inflammatory reactions were
observed after 48 hours.
DISCUSSION
From experiments on animals it could be
anticipated that methylation of histamine would
involve a biologic inactivation of the amine also
in man. The very slight biologic activity of
* No reaction to 1:1,000.
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methyl-histamine demonstrated in our experi-
ments, an activity less than 1:1,000 of that of
histamine is, in fact, the most pronounced inac-
tivation of histamine by methylation found in
any species. This inactivation by methylation of
histamine takes place very rapidly in the human
organism (13, 14, 15).
SUMMARY
The exudatory and vasodilatory effects in the
skin of 1-methyl-4-beta-aminoethyl imidazolc,
which is an important metabolic product in
human histamine catabolism, has been examined
in ten healthy subjects.
The exudatory effect of methyl-histamine is
less than a thousandth of that of histamine and
the vasodilatatory effect is about a thousand
times less than that of histamine.
No delayed inflammatory phenomena were
produced by methyl-histamine.
The results indicate that the quantitatively
important methylation of histamine in man
also means an important inactivation of the
amine with regard to its vascular effects in
human skin.
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